Salarius Pharmaceuticals, INC. (DCOY) SEC Filings — 2025
42 SEC filings for Salarius Pharmaceuticals, INC. (DCOY) in 2025.
Filings
- Salarius Pharmaceuticals Files 8-K — 8-K · Dec 19, 2025
- Salarius Pharmaceuticals Announces Board and Executive Changes — 8-K · Nov 19, 2025
- Salarius Pharmaceuticals, INC. 8-K Filing — 8-K · Nov 17, 2025
- Salarius Narrows Losses, Boosts Cash Post-Decoy Merger — 10-Q · Nov 14, 2025
- Salarius Pharmaceuticals Reports Multiple Material Events — 8-K · Nov 13, 2025
- Salarius Pharma Sets Dec. 19 Annual Meeting, Board Backs All Proposals — DEF 14A · Nov 7, 2025
- Salarius to Offer 1.96M Shares, Warrants for Decoy Merger — S-1/A · Oct 21, 2025
- Salarius Pharmaceuticals Reports Director Changes and Compensation Updates — 8-K · Oct 21, 2025
- Salarius Pharmaceuticals Files 8-K — 8-K · Oct 14, 2025
- Salarius Pharmaceuticals Files 8-K — 8-K · Oct 6, 2025
- Salarius Seeks $6M to Seal Decoy Merger, Nasdaq Listing Hinges on Shareholder Vote — S-1/A · Sep 23, 2025
- Salarius Pharmaceuticals Files 8-K — 8-K · Sep 18, 2025
- Salarius Pharmaceuticals Changes Office Address — 8-K · Sep 9, 2025
- Salarius Pharmaceuticals Files 8-K: "Other Events" — 8-K · Aug 27, 2025
- Salarius Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Aug 26, 2025
- Salarius Pharmaceuticals Files 8-K — 8-K · Aug 22, 2025
- Salarius Pharmaceuticals Board Shake-up — 8-K · Aug 18, 2025
- Salarius Pharmaceuticals Files 8-K with Key Corporate Updates — 8-K · Aug 15, 2025
- Salarius Posts Q2 Net Loss of $5.5M, Continues Equity Funding — 10-Q · Aug 12, 2025
- Salarius Pharma Updates S-1/A, Reports $5.5M Net Loss in 2024 — S-1/A · Aug 8, 2025
- Salarius Faces Mounting Losses, Seeks Fresh Capital Amid S-1/A Filing — S-1/A · Jul 31, 2025
- Salarius Pharmaceuticals Files 8-K on Operations and Equity Sales — 8-K · Jul 31, 2025
- Salarius Pharmaceuticals Files 8-K — 8-K · Jul 29, 2025
- Salarius Pharmaceuticals Relocates Offices — 8-K · Jul 28, 2025
- Salarius Pharmaceuticals Files 8-K: Material Agreement & Security Holder Changes — 8-K · Jul 21, 2025
- Salarius Pharmaceuticals Files 8-K — 8-K · Jul 14, 2025
- Salarius Pharmaceuticals Reports Shareholder Vote Matters — 8-K · Jul 8, 2025
- Salarius Narrows Losses to $16.7M, Extends Runway to Q3 2025 — S-1/A · Jun 16, 2025
- Salarius Pharmaceuticals Files 8-K — 8-K · Jun 16, 2025
- Salarius Pharmaceuticals Files 8-K — 8-K · Jun 11, 2025
- Salarius Seeks Reverse Split, Capital Infusion to Bolster Nasdaq Listing — DEF 14A · May 27, 2025
- Salarius Narrows Loss to $19.9M, Seeks Fresh Capital for Drug Trials — S-1/A · May 22, 2025
- Salarius Pharmaceuticals Files Preliminary Proxy Statement — DEF 14A · May 15, 2025
- Salarius Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Salarius Pharmaceuticals Faces Delisting Notice — 8-K · Apr 25, 2025
- Salarius Pharmaceuticals Files S-1/A Update — S-1/A · Apr 17, 2025
- Salarius Pharmaceuticals Faces Delisting Concerns — 8-K · Mar 28, 2025
- Salarius Pharmaceuticals Files 2024 10-K — 10-K · Mar 21, 2025
- Salarius Pharmaceuticals Files 8-K — 8-K · Mar 11, 2025
- Salarius Pharmaceuticals Files S-1 for Potential Stock Offering — S-1 · Jan 21, 2025
- Salarius Pharmaceuticals Files 8-K on Operations and Equity Sales — 8-K · Jan 17, 2025
- Salarius Pharmaceuticals, INC. 8-K Filing — 8-K · Jan 13, 2025